血红蛋白和血糖水平对CT灌注缺血核心估算的影响:ESCAPE-NA1试验的事后分析
该研究为ESCAPE-NA1试验的事后分析,纳入162例基线CT灌注检查后行取栓且近完全再灌注的大血管闭塞卒中患者,比较贫血与非贫血、高血糖与血糖正常组的灌注缺损(核心低估)。高血糖组灌注缺损更常见且核心低估体积更大,多变量回归显示高血糖与灌注缺损相关(校正OR 2.48,95%CI 1.25-4.92),血糖每升高1 mmol/L校正OR为1.19(95%CI 1.03-1.39)。
要点
- 162例大血管闭塞卒中患者中48%存在灌注缺损(核心低估≥10 mL)。
- 高血糖组灌注缺损65%(n=40)vs 血糖正常组39%(n=38),p=0.006。
- 高血糖组核心低估体积中位数17.79 mL vs 血糖正常组6 mL,p=0.003。
核心结论
- 基于CT灌注的缺血核心低估常见,且与基线血糖水平较高相关。
- 解读基线CT灌注缺血核心估算时,应考虑灌注以外影响梗死生长速率的个体代谢因素。
研究设计与样本
- ESCAPE-NA1试验的事后分析,纳入基线CT灌注检查后行取栓且近完全再灌注、无实质出血的大血管闭塞卒中患者。
- 共纳入162/1105例(15%)患者,中位年龄70.5岁(IQR 61-80.4),女性50.6%。
- 按血红蛋白水平分为贫血组(男性<130 g/L,女性<120 g/L)与非贫血组,按血糖水平分为高血糖组(>7 mmol/L)与血糖正常组。
- 核心低估体积(ICuV)=最终梗死体积−CTP基于的缺血核心体积。
- 主要结局为灌注缺损(ICuV≥10 mL),采用非参数检验和多变量二分类logistic回归(校正基线变量)比较组间差异。
主要发现
- 中位ICuV为7.26 mL(IQR 0-25.63),78例(48%)患者存在灌注缺损。
- 42例(25.7%)贫血,65例(40.1%)高血糖。
- 单变量分析中,高血糖组灌注缺损比例65%(n=40)vs 血糖正常组39%(n=38),p=0.006。
- 高血糖组ICuV中位数17.79 mL(IQR 1.57-42.75)vs 血糖正常组6 mL(IQR -0.31至12.51),p=0.003。
- 贫血组与非贫血组ICuV无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: CT perfusion (CTP) maps can estimate the ischemic core in acute ischemic stroke based on distinctive cerebral blood flow thresholds. However, metabolic factors beyond perfusion influence the tissue tolerance to ischemia and the infarct growth rate. Underestimating the ischemic core volume (ICV) might result in overestimating the salvageable cerebral tissue and, consequently, overestimating the potential clinical benefits of reperfusion therapies. We aim to evaluate whether baseline hemoglobin and blood glucose levels influence the accuracy of baseline CTP ICV estimations. METHODS: Large vessel occlusion stroke patients investigated with baseline CTP undergoing thrombectomy with near-complete reperfusion and without parenchymal hemorrhage from the ESCAPE-NA1 trial were included. Patients were subdivided into anemic (hemoglobin <130 g/L for men and <120 g/L for women) and nonanemic groups, and hyperglycemic (blood glucose level >7 mmol/L) and normoglycemic groups. Ischemic core underestimated volume (ICuV) was calculated: final infarct volume minus CTP-based ICV. The primary outcome was the presence of "perfusion scotoma" defined as ICuV ≥10 mL. Presence of "perfusion scotoma" and median ICuV were compared between anemic vs nonanemic and hyperglycemic vs normoglycemic patients using nonparametric tests and multivariable binary logistic regression with adjustment for baseline variables. RESULTS: One hundred sixty-two of 1,105 (15%) patients were included (median age 70.5 [interquartile range (IQR) 61-80.4], 50.6% women). The median ICuV was 7.26 mL (IQR 0-25.63). Seventy-eight (48%) patients demonstrated perfusion scotoma. Forty-two (25.7%) patients were anemic, and 65 (40.1%) were hyperglycemic. In univariable analysis, the hyperglycemic group had a higher prevalence of perfusion scotoma (65% [n = 40] vs 39% [n = 38], p = 0.006) and larger ICuV (17.79 mL [IQR 1.57-42.75] vs 6 mL [-0.31 to 12.51], p = 0.003) compared to normoglycemic patients. No significant ICuV differences between patients with and without anemia were seen. Multivariable regression analysis revealed an association between perfusion scotoma and hyperglycemia, adjusted odds ratio (OR) 2.48 (95% CI 1.25-4.92), and between perfusion scotoma and blood glucose levels, adjusted OR 1.19 (95% CI 1.03-1.39) per 1 mmol/L increase. DISCUSSION: In our study, CTP-based ischemic core underestimation was common and associated with higher baseline blood glucose levels. Individual metabolic factors beyond perfusion that critically influence the infarct growth rate should be considered when interpreting baseline CTP estimations of ischemic core.
引用
- Pensato U, Bosshart S, Stebner A, et al. Effect of Hemoglobin and Blood Glucose Levels on CT Perfusion Ischemic Core Estimation: A Post Hoc Analysis of the ESCAPE-NA1 Trial. Neurology. 2024. PMID: 39432874. doi:10.1212/WNL.0000000000209939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。